FDNA and Centogene Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting

October 17, 2016

BUSINESS WIRE – “Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant of molecular testing for a patient with an unknown genetic disorder. The collaboration extends beyond financial support and includes the successful integration of Face2Gene LABS API with CENTOGENE’s bioinformatics pipeline to improve variant prioritization and analysis of patients with undiagnosed genetic disorders using deep phenotyping and facial analysis technology.”